Description

Moxonidine

CAS-Nr.: 75438-57-2

Usage: Moxonidine is a new-generation centrally acting antihypertensive drug licensed for the treatment of mild to moderate essential hypertension. It may have a role when thiazides, beta-blockers, ACE inhibitors and calcium channel blockers are not appropriate or have failed to control blood pressure. In addition, it demonstrates favourable effects on parameters of the insulin resistance syndrome, apparently independent of blood pressure reduction.

Product characteristics

• Formula: C9H12ClN5O
• Quality Ph. Eur.
• Origin Czech Republic
• DMF-Status CEP available
• GMP-Status EU-GMP available
• White Solid
• Minimum order quantity 100 kg
• Packaging: 25 kg drum